The current institutional shareholding score of Urogen Pharma Ltd is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 95.00%, representing a quarter-over-quarter decrease of 7.96%. The largest institutional shareholder is Catherine Wood, holding a total of 70.92K shares, representing 0.24% of shares outstanding, with 1.18% increase in holdings.